ReviewFrontiers in immunology2026
Molecular basis of coronary artery disease-malignancy comorbidity: inflammation, immunometabolism, thrombosis, and cardio-oncology translation.
Junlin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.